Natural Killer (NK) Cell Therapeutics Market to Reach USD 5.09 Billion by 2026 : Allied Market Research
NK Cell Therapeutics market was projected at $1.40 billion in 2018 and is expected to hit $5.09 billion by 2026, registering a CAGR of 17.4%
PORTLAND, OR, UNITED STATES, June 8, 2023/EINPresswire.com/ -- The global NK Cell Therapeutics market was projected at $1.40 billion in 2018 and is expected to hit $5.09 billion by 2026, registering a CAGR of 17.4% during 2019โ2026.
Rise in use of NK cells for the treatment of infections & liver diseases, surge in awareness among the population regarding various immunotherapies, and increase in R&D for the development of bi-specific antibody for engaging NK cells to eliminate tumor cells propel the growth of the global NK cell therapeutics market. On the other hand, lack of specificity & poor in-vivo survival of the cells, higher costs associated with the therapies, and their adverse side effects restrain the growth of the market to some extent. However, significant surge in R&D activities toward development of immunotherapy in developing economies is anticipated to create lucrative opportunities in the near future.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ : https://www.alliedmarketresearch.com/request-sample/2132
๐๐ก๐ ๐๐ ๐๐๐ฅ๐ฅ-๐๐ข๐ซ๐๐๐ญ๐๐ ๐๐ง๐ญ๐ข๐๐จ๐๐ข๐๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฅ๐๐๐ ๐ญ๐ก๐ ๐ญ๐ซ๐๐ข๐ฅ ๐ญ๐ข๐ฅ๐ฅ ๐๐๐๐
Based on therapeutics, the NK cell-directed antibodies segment accounted for nearly three-fifths of the total market share in 2018 and is anticipated to rule the roost during the estimated period. Increase in usage of monoclonal antibodies for the treatment of various diseases and its easy availability spur the growth. At the same time, the NK cell therapies segment would grow at the fastest CAGR of 17.6% till 2026. Extensive research in developing NK cell therapeutics to treat cancer is the major factor driving the growth.
๐๐ก๐ ๐๐๐ง๐๐๐ซ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ ๐๐ง๐๐ซ๐๐ญ๐๐ ๐ญ๐ก๐ ๐ก๐ข๐ ๐ก๐๐ฌ๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐๐๐๐-
Based on application, the cancer segment contributed to more than three-fourths of the total market revenue in 2018 and is expected to dominate through 2019โ2026. This is attributed to significant increase in the prevalence of cancer in this region. The gastrointestinal diseases segment, on the other hand, is projected to grow at the fastest CAGR of 19.3% during the forecast period. This is attributed to the rising growth in geriatric population, and improvement in healthcare facilities in the province.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐ ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ) @ https://www.alliedmarketresearch.com/checkout-final/0bb390aeeaa38cc4eae548152f3d6176
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ญ๐จ ๐๐ ๐๐จ๐ฆ๐ข๐ง๐๐ง๐ญ ๐๐ฒ ๐๐๐๐-
Based on geography, North America held the major share in 2018, accounting for nearly half of the total market. Surge in the incidence of cancer in the region has driven the growth. At the same time, the Asia-Pacific region is predicted to showcase the fastest CAGR of 19.5% throughout the study period.
๐๐๐ญ๐ฎ๐ซ๐๐ฅ ๐๐ข๐ฅ๐ฅ๐๐ซ ๐๐๐ฅ๐ฅ๐ฌ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
The key market players analyzed in the report include Affimed N.V., Altor BioScience Corporation, Chipscreen Biosciences, Ltd., NKT Therapeutics, Inc., Innate Pharma S.A., Sorrento Therapeutics Inc., NantKwest Inc., Bristol-Myers Squibb, Takeda Pharmaceutical Company Limited, and others. Incorporating a number of high-end strategies including expansions, mergers & acquisitions, partnerships, joint ventures, collaborations, and others, these market players have become able to heighten their stand in the industry.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/2132
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
Central Lab Market Size: https://www.alliedmarketresearch.com/central-lab-market-A15406
Gene Synthesis Market Share: https://www.alliedmarketresearch.com/gene-synthesis-market-A39015
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
+ 1-800-792-5285
email us here